Valaris Limited

NYSE:VAL Rapport sur les actions

Capitalisation boursière : US$3.3b

Valaris Bilan de santé

Santé financière contrôle des critères 5/6

Valaris possède un total de capitaux propres de $2.1B et une dette totale de $1.1B, ce qui porte son ratio d'endettement à 50.9%. Son actif total et son passif total sont $4.3B et de $2.2B. L'EBIT de Valaris est $287.4M ce qui fait que son ratio de couverture des intérêts -23.4. Elle dispose de liquidités et de placements à court terme de $379.3M.

Informations clés

50.9%

Ratio d'endettement

US$1.08b

Dette

Ratio de couverture des intérêts-23.4x
Argent liquideUS$379.30m
Fonds propresUS$2.12b
Total du passifUS$2.21b
Total des actifsUS$4.33b

Mises à jour récentes de la santé financière

Valaris (NYSE:VAL) Is In A Good Position To Deliver On Growth Plans

Aug 04
Valaris (NYSE:VAL) Is In A Good Position To Deliver On Growth Plans

Recent updates

Valaris' (NYSE:VAL) Performance Raises Some Questions

Nov 08
Valaris' (NYSE:VAL) Performance Raises Some Questions

Valaris Limited Just Missed EPS By 15%: Here's What Analysts Think Will Happen Next

Nov 02
Valaris Limited Just Missed EPS By 15%: Here's What Analysts Think Will Happen Next

Returns On Capital Are Showing Encouraging Signs At Valaris (NYSE:VAL)

Sep 13
Returns On Capital Are Showing Encouraging Signs At Valaris (NYSE:VAL)

Here's Why We Think Valaris (NYSE:VAL) Is Well Worth Watching

Aug 23
Here's Why We Think Valaris (NYSE:VAL) Is Well Worth Watching

Valaris: Good Quarter, But Near-Term Outlook Disappoints - Buy

Aug 16

Valaris: Major Earnings Inflection Ahead, Buy

Jun 10

Valaris: Buy Despite Near-Term Jackup Market Headwinds

Apr 02

Valaris Limited: Promising Outlook As Meaningful FCF Commences

Feb 10

Valaris: Weak Quarter, But Long-Term Prospects Remain Intact - Buy

Nov 21

Valaris: Uncovering Cash Flow Potential To Buy Back Shares

Oct 05

Valaris: Buy On Strong Medium-Term Earnings Outlook And Inexpensive Valuation

Aug 22

Valaris: Shares Still Cheap

Jul 21

Valaris Stock: Revenue And Profit Growth Trends Indicate Undervaluation

Jul 12

Valaris: Upgrading Shares On Improved Financial Flexibility And Strong Buyback Commitment

Jun 05

Valaris Q4 2022 Earnings Preview

Feb 20

Valaris: Benefiting From Offshore Boom

Jan 29

Valaris secures contract awards with backlog of roughly $275M

Dec 16

Valaris Limited: Some Progress

Nov 08

Valaris Q3 2022 Earnings Preview

Oct 31

Valaris: Leveraging On Scale A Year After Bankruptcy

Oct 06

Valaris says Matt Lyne has joined as new chief commercial officer

Sep 26

Valaris announces $100M stock buyback program

Sep 08

Valaris Q2 2022 Earnings Preview

Aug 01

Valaris reports $466M in associated contract backlog, updates fleet status

Jul 05

Valaris: Jackup Sale To ADES Is Great News

Apr 28

Valaris Report Highlights The Current Situation With Long-Term Contracts

Feb 22

Valaris Limited: A Decent Third Quarter

Nov 17

Valaris Ltd.: Starting Again And Hoping For A New Outcome This Time

Oct 24

Valaris (NYSE:VAL) Is In A Good Position To Deliver On Growth Plans

Aug 04
Valaris (NYSE:VAL) Is In A Good Position To Deliver On Growth Plans

Valaris: Outlook Improves As Company Is Set To Reactivate Rigs

Aug 04

Valaris awarded three year contract with Chevron

Jun 08

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de VAL ( $1.1B ) dépassent ses passifs à court terme ( $692.3M ).

Passif à long terme: Les actifs à court terme de VAL ( $1.1B ) ne couvrent pas ses passifs à long terme ( $1.5B ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de VAL ( 33.1% ) est considéré comme satisfaisant.

Réduire la dette: Le ratio d'endettement de VAL a été réduit de 64.7% à 50.9% au cours des 5 dernières années.

Couverture de la dette: La dette de VAL est bien couverte par le flux de trésorerie opérationnel ( 30.3% ).

Couverture des intérêts: VAL gagne plus d'intérêts qu'il n'en paie, donc la couverture des paiements d'intérêts n'est pas un problème.


Bilan


Découvrir des entreprises saines